Clinical Trial: Implementation of Pre-emptive Pharmacogenomics Testing in Singapore-based Private Hospital Institutions (PPT Study)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Pre-emptive Pharmacogenomics
Study Type: OBSERVATIONAL
Official Title: Implementation of Pre-emptive Pharmacogenomics Testing in Singapore-based Private Hospital Institutions (PPT Study)
Brief Summary:
In collaboration with Raffles Medical Group, we will be recruiting 500 patients and following them for the next 3-12 months to see whether pharmacogenomics information provided in the Raffles' Electronic Health Records (EHR) will be used by physicians to personalize patients' prescriptions.
Read more